Pentwater Capital Management’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Pentwater Capital Management’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,000,000	Closed	-$16.9M	–	196
2014 Q4	$16.9M	Buy	+1,000,000	New	+$14.1M	0.12%	73

Pentwater Capital Management's AVNR Position: Q1 2015 in Review

Pentwater Capital Management sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 1,000,000 shares — an estimated $16.9M sold.

Pentwater Capital Management first reported a position in AVNR in Q4 2014 and held it in 1 quarter. The position peaked at $16.9M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Pentwater Capital Management reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Pentwater Capital Management sold 1,000,000 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $16.9M.
Pentwater Capital Management first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2014 and held it in 1 quarter.
Pentwater Capital Management's AVANIR PHARMACEUTICALS, INC CL A position peaked at $16.9M in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Pentwater Capital Management's 13F filing for Q1 2015, filed 15 May 2015.